Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.06% |
| 2 | Consumer Discretionary | 1.41% |
| 3 | Healthcare | 0.83% |
| 4 | Financials | 0.79% |
| 5 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
Celldex Therapeutics
CLDX
$3.29B
| $1.94M | ﹤0.01% |
48,888
-8,572
| -15% | -$252K |
|
5377
CALL
SkinHealth Systems
SKIN
$86.8M
| $1.94M | ﹤0.01% |
623,000
+84,100
| +16% | +$316K |
|
5378
CALL
WD-40
WDFC
$3.08B
| $1.94M | ﹤0.01% |
8,100
-16,500
| -67% | -$3.68M |
|
5379
PUT
Tradeweb Markets
TW
$22.4B
| $1.94M | ﹤0.01% |
21,300
-300
| -1% | -$26.8K |
|
5380
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.8B
| $1.94M | ﹤0.01% |
17,694
+14,968
| +549% | +$1.55M |
|
5381
Five Below
FIVE
$13.5B
| $1.93M | ﹤0.01% |
9,073
-29,109
| -76% | -$5.34M |
|
5382
Outfront Media
OUT
$5.33B
| $1.93M | ﹤0.01% |
140,729
+130,242
| +1,242% | +$1.47M |
|
5383
CALL
CubeSmart
CUBE
$9.34B
| $1.93M | ﹤0.01% |
41,700
+12,700
| +44% | +$499K |
|
5384
CALL
MoonLake Immunotherapeutics
MLTX
$1.4B
| $1.93M | ﹤0.01% |
32,000
-1,000
| -3% | -$51.5K |
|
5385
ARK Genomic Revolution ETF
ARKG
$1.74B
| $1.93M | ﹤0.01% |
58,808
-4,140
| -7% | -$113K |
|
5386
Ecovyst
ECVT
$1.14B
| $1.93M | ﹤0.01% |
197,335
-63,078
| -24% | -$601K |
|
5387
Vaxcyte
PCVX
$8.64B
| $1.93M | ﹤0.01% |
30,698
+8,993
| +41% | +$467K |
|
5388
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.34B
| $1.93M | ﹤0.01% |
36,698
+31,444
| +598% | +$1.57M |
|
5389
CALL
Patrick Industries
PATK
$2.76B
| $1.93M | ﹤0.01% |
28,800
-3,150
| -10% | -$173K |
|
5390
ICICI Bank
IBN
$107B
| $1.93M | ﹤0.01% |
80,808
-202,767
| -72% | -$4.67M |
|
5391
Regal Rexnord
RRX
$11.7B
| $1.92M | ﹤0.01% |
12,993
-39,120
| -75% | -$4.94M |
|
5392
CALL
Direxion Daily Healthcare Bull 3X ETF
CURE
$187M
| $1.92M | ﹤0.01% |
18,900
+10,400
| +122% | +$932K |
|
5393
PUT
Cirrus Logic
CRUS
$6.07B
| $1.92M | ﹤0.01% |
23,100
-23,100
| -50% | -$1.73M |
|
|
ROVR
5394
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $1.92M | ﹤0.01% |
176,617
-65,641
| -27% | -$555K |
|
5395
Pacer Data & Infrastructure Real Estate ETF
SRVR
$391M
| $1.92M | ﹤0.01% |
64,430
+1,553
| +2% | +$42.2K |
|
5396
PUT
Oxford Industries
OXM
$543M
| $1.92M | ﹤0.01% |
19,200
-32,800
| -63% | -$3.05M |
|
5397
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
| $1.92M | ﹤0.01% |
32,845
-51,083
| -61% | -$2.79M |
|
5398
Acumen Pharmaceuticals
ABOS
$193M
| $1.92M | ﹤0.01% |
499,794
+322,015
| +181% | +$956K |
|
5399
American Superconductor
AMSC
$1.55B
| $1.92M | ﹤0.01% |
172,225
+79,360
| +85% | +$671K |
|
5400
AbCellera Biologics
ABCL
$3.49B
| $1.92M | ﹤0.01% |
335,992
+95,767
| +40% | +$444K |
|
Similar funds
Susquehanna International Group's Q4 2023 Portfolio in Review
As of Q4 2023, Susquehanna International Group held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Susquehanna International Group's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Susquehanna International Group's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Susquehanna International Group added most to Alibaba in Q4 2023, an estimated $422M increase.
- Susquehanna International Group's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Susquehanna International Group fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Susquehanna International Group's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Susquehanna International Group opened 1,903 new positions and closed 1,577 in Q4 2023.
- Susquehanna International Group's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.